Next steps for Eli Lilly, Novo Nordisk, Pfizer
A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, Jan. 15, 2026. George…
How Pfizer’s AI and Precision Oncology Deals At Pfizer (PFE) Have Changed Its Investment Story
In early January 2026, Pfizer Inc. and Boltz, PBC announced a collaboration to apply biomolecular AI foundation models…
What You Need to Know
Pfizer Inc. (PFE), headquartered in New York, discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products. With a…
Johnson & Johnson halts mid-stage trial of experimental eczema drug
Johnson & Johnson offices in Irvine, California, US, on Friday, Oct. 10, 2025. Kyle Grillot | Bloomberg |…
FDA Pulls Warning Labels From Hormone Replacement Therapies
Hormone replacement therapies used to treat menopause symptoms no longer need to carry strict warnings about some potential…
Metsera Weight-Loss Drug Shows ‘Excellent’ Tolerability in Study
Metsera Inc.’s next-generation weight-loss drug showed good tolerability with few participants dropping out of a mid-stage trial, adding…
Lilly, Novo to Lower Obesity Drug Prices in Deal with Trump
Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for…
Metsera calls Novo Nordisk’s new bid superior to Pfizer offer
The logos of Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy…
US, Canada Face Loss of Measles Elimination Status by WHO
Hi, it’s Jessica in Washington. A key meeting starts today that will decide measles elimination status for the…
Pfizer files second lawsuit against Novo Nordisk, Metsera
A Pfizer logo is displayed at a research facility in the La Jolla neighborhood of San Diego, California,…
Pfizer sues Metsera, Novo Nordisk over rival obesity drug bid
Thomas Fuller | SOPA Images | Lightrocket | Getty Images Pfizer said on Friday it had filed a lawsuit against Metsera and Novo…
Why an Old Multiple Sclerosis Drug Costs More Than Ever in the US
When Jean Kay started a brand-new multiple sclerosis treatment called Rebif in 2003, it cost $17,500 a year.…